Pharmaceutical Price Control Policy, Pharmaceutical Innovation, and Health Durability
نویسندگان
چکیده
Background: The increase in R&D and upward trend of R&D/pharmaceutical sales has occurred despite government controlled pharmaceutical price reduction in Japan. This paper identifies the effect of the government’s price control policy on pharmaceutical innovation and evaluates the influence of new chemical entities (NCE) on health
منابع مشابه
Innovation and Drug Reimportation: Cost, Value, and Tradeoffs – Economic, Legal, and Public Policy Implications
Innovation and Drug Reimportation: Cost, Value, and Tradeoffs – Economic, Legal, and Public Policy Implications Based on the proceedings of a University of Michigan Center for Medication Use, Policy and Economics symposium, April 18–20, 2004,Washington, D.C. HIGHLIGHTS • Legislation and Pharmaceutical Reimportation • Price Regulation and Innovation • Price Differentials Between Canada and the U...
متن کاملToward a definition of pharmaceutical innovation
ONGOING DEBATES IN THE PHARMACEUTICAL SECTOR ABOUT INTELLECTUAL PROPERTY, PRICING AND REIMBURSEMENT, AND PUBLIC RESEARCH INVESTMENTS HAVE A COMMON DENOMINATOR: the pursuit of innovation. However, there is little clarity about what constitutes a true pharmaceutical innovation, and as a result there is confusion about what kind of new products should be pursued, protected and encouraged through h...
متن کاملOft, Vbp: Qed?
The report by the Office of Fair Trading (OFT) on the UK pharmaceutical price regulation scheme (PPRS) recommends the reform of the current scheme, which is a combination of profit and price controls, to one where price is based on the health benefits offered by a pharmaceutical. On closer examination some of the more commonly expressed concerns about these proposals do not seem to be well foun...
متن کاملBalancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.
INTRODUCTION Policy-makers worldwide struggle to balance health with industrial policy objectives in the pharmaceutical sector. Tensions arise over pricing and reimbursement in particular. What health plans view as necessary to maintain equitable access to medicines, industry views as inimical to R&D and innovation. Australia has grappled with this issue for years, even incorporating the goal o...
متن کاملPolicy approaches to improve availability and affordability of medicines in Mexico – an example of a middle income country
BACKGROUND The World Health Organization recommends establishing and implementing a national pharmaceutical policy (NPP) to guarantee effective and equitable access to medicines. Mexico has implemented several policy approaches to regulate the pharmaceutical sector, but it has no formal NPP. This article describes the approach that the Mexican government has taken to improve availability and af...
متن کامل